Deeg H J, Storb R, Raff R F, Weiden P L, DeRose S, Thomas E D
Transplantation. 1982 Jan;33(1):17-21. doi: 10.1097/00007890-198201000-00004.
Bone marrow transplants with low marrow cell doses (less than or equal to 4 x 10(8) cells/kg) from unrelated donors were carried out in 16 dogs conditioned with 9 Gy (900 rad) of total body irradiation. No immunosuppression was given after grafting. Eleven donor-recipient pairs were phenotypically identical (group 1) for the known antigens of the canine major histocompatibility complex (DLA) and in five the donor was homozygous and the recipient heterozygous for DLA (group 2), as determined by serological histocompatibility typing and mixed leukocyte cultures including homozygous cell typing. In addition, lymphocytes from donors and recipients in group 1 were mutually nonreactive in cell-mediated lympholysis; lymphocytes from recipients in group 2 were not cytotoxic against donor cells. Eight dogs rejected their grafts and eight showed sustained engraftment; of these, four died from graft-versus-host disease. The incidence of rejection was higher than in DLA-identical littermates but lower than in DLA-nonidentical unrelated or littermate dogs. These results indicate that antigens different from the recognized alleles at DLA are involved in the control of engraftment. These antigens most likely represent the expression of unrecognized differences within DLA or are coded for by a locus different from but linked to DLA-A, B, C or D; they are not recognized in the cell-mediated lympholysis assay.
对16只接受9戈瑞(900拉德)全身照射预处理的犬进行了来自无关供体的低骨髓细胞剂量(小于或等于4×10⁸ 细胞/千克)的骨髓移植。移植后未给予免疫抑制。通过血清学组织相容性分型和包括纯合细胞分型在内的混合淋巴细胞培养确定,11对供体-受体在犬主要组织相容性复合体(DLA)的已知抗原方面表型相同(第1组),5对供体为DLA纯合子而受体为杂合子(第2组)。此外,第1组供体和受体的淋巴细胞在细胞介导的淋巴细胞溶解中相互无反应;第2组受体的淋巴细胞对供体细胞无细胞毒性。8只犬排斥了它们的移植物,8只显示移植物持续植入;其中4只死于移植物抗宿主病。排斥发生率高于DLA相同的同窝仔犬,但低于DLA不同的无关或同窝仔犬。这些结果表明,与DLA公认等位基因不同的抗原参与了植入的控制。这些抗原很可能代表DLA内未被识别的差异的表达,或者由与DLA-A、B、C或D不同但与之连锁的位点编码;它们在细胞介导的淋巴细胞溶解试验中未被识别。